ES8900019A1 - Un procedimiento para fabricar una proteina de la superficiede las celulas - Google Patents

Un procedimiento para fabricar una proteina de la superficiede las celulas

Info

Publication number
ES8900019A1
ES8900019A1 ES543635A ES543635A ES8900019A1 ES 8900019 A1 ES8900019 A1 ES 8900019A1 ES 543635 A ES543635 A ES 543635A ES 543635 A ES543635 A ES 543635A ES 8900019 A1 ES8900019 A1 ES 8900019A1
Authority
ES
Spain
Prior art keywords
cell surface
surface protein
fibrinogen
collagen
fibronectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES543635A
Other languages
English (en)
Other versions
ES543635A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfa Laval Agri International AB
Original Assignee
Alfa Laval Agri International AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Laval Agri International AB filed Critical Alfa Laval Agri International AB
Publication of ES8900019A1 publication Critical patent/ES8900019A1/es
Publication of ES543635A0 publication Critical patent/ES543635A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

EL PROCEDIMIENTO CONSISTE EN: A) CULTIVO DE UNA CABA PACTERIANA SELECCIONADA DEL GRUPO FORMADO POR STAPHILOCOCUS, STREPTOCOCCUS Y ESCHERICHIA COLI, QUE TIENEN LA CAPACIDAD DE UNIRSE A FIBRINOGENO, FIBRONECTINA, COLAGENO Y/O LAMINIA; EL CULTIVO SE REALIZARA EN UN MEDIO SOLIDO O LIQUIDO A UNA TEMPERATURA COMPRENDIDA ENTRE 15-40GC DURANTE 6-60 HORAS; 2) AISLAMIENTO Y LAVADO DE LA CEPA BASTERIANA CULTIVADA; 3) DESCOMPOSICION MEDIANTE ENZIMA BACTERIOLITICA A UNA TEMPERATURA DE 25-40GC DURANTE 0,1 A 1 HORA; 4) PURIFICACION DEL COMPONENTE DE UNION A FIBRONECTINA, FIBRINOGENO, COLAGENO Y/O LAMININA POR MEDIO DE UNA TECNICA DE SEPARACION BIOQUIMICA. APLICABLE CON FINES PROFILACTICOS PARA EL TRATAMIENTO DE ANIMALES Y PERSONAS, DADA LA POSIBILIDAD DE BLOQUEO, EN UN TEJIDO CON HERIDA TRAUMATICA, DE FIBRINOGENO, FIBRONECTINA, COLAGENO Y/O LAMININA CON EL FIN DE EVITAR LA ADHERENCIA DE CEPAS BACTERIANAS PATOGENAS A ESTOS.
ES543635A 1984-05-30 1985-05-29 Un procedimiento para fabricar una proteina de la superficiede las celulas Expired ES8900019A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8402938A SE454403B (sv) 1984-05-30 1984-05-30 Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel

Publications (2)

Publication Number Publication Date
ES8900019A1 true ES8900019A1 (es) 1988-11-01
ES543635A0 ES543635A0 (es) 1988-11-01

Family

ID=20356083

Family Applications (1)

Application Number Title Priority Date Filing Date
ES543635A Expired ES8900019A1 (es) 1984-05-30 1985-05-29 Un procedimiento para fabricar una proteina de la superficiede las celulas

Country Status (13)

Country Link
EP (1) EP0163623B1 (es)
JP (1) JPH0747541B2 (es)
AT (1) ATE52543T1 (es)
AU (1) AU600886B2 (es)
CA (1) CA1340401C (es)
DE (1) DE3577579D1 (es)
ES (1) ES8900019A1 (es)
FI (1) FI84431C (es)
IE (1) IE59203B1 (es)
NO (1) NO164992C (es)
NZ (1) NZ212244A (es)
SE (1) SE454403B (es)
WO (1) WO1985005553A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702272L (sv) * 1987-06-01 1988-12-02 Alfa Laval Agri Int Fibronektinbindande protein samt dess framstaellning
SE8801723D0 (sv) * 1988-05-06 1988-05-06 Staffan Normark Fibronectin binding protein as well as its preparation
SE8801894D0 (sv) * 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
SE8901687D0 (sv) * 1989-05-11 1989-05-11 Alfa Laval Agri Int Fibronectin binding protein as well as its preparation
US5440014A (en) * 1990-08-10 1995-08-08 H+E,Uml/Oo/ K; Magnus Fibronectin binding peptide
SE9003374D0 (sv) * 1990-10-22 1990-10-22 Alfa Laval Agri Int A collagen binding protein as well as its preparation
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
AU4837193A (en) * 1992-09-21 1994-04-12 Alfa-Laval Agri International Aktiebolag Fibrinogen binding protein
JPH0840932A (ja) * 1994-07-29 1996-02-13 Kitasato Inst:The スタフイロコッカス属菌感染症の予防ワクチン及び治療用抗体並びにそれの製造法
GB9415902D0 (en) * 1994-08-05 1994-09-28 Smithkline Beecham Plc Method of treatment
US6685943B1 (en) 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
IL141639A (en) * 1998-08-31 2005-12-18 Inhibitex Inc Multicomponent vaccines
US6908994B1 (en) 1999-05-10 2005-06-21 The Texas A&M University System Collagen-binding proteins from enterococcal bacteria
BRPI0408167B1 (pt) 2003-03-07 2014-10-21 Wyeth Corp Conjugados de polissacarídeo-proteína veículo adesina da superfície estafilocócica para imunização contra infecções nosocomiais
KR20080042865A (ko) * 2005-08-10 2008-05-15 아르네 포르스그렌 아베 모락셀라 카타랄리스와 상피세포, 세포외기질 단백질 및보체계의 상호작용
PE20110023A1 (es) 2009-06-22 2011-01-31 Wyeth Llc Composiciones inmunogenicas de antigenos de staphylococcus aureus
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
TW201302779A (zh) 2011-04-13 2013-01-16 Glaxosmithkline Biolog Sa 融合蛋白質及組合疫苗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide

Also Published As

Publication number Publication date
EP0163623A3 (en) 1987-02-25
ATE52543T1 (de) 1990-05-15
FI84431B (fi) 1991-08-30
DE3577579D1 (de) 1990-06-13
IE851337L (en) 1985-11-30
NO860321L (no) 1986-01-29
SE8402938D0 (sv) 1984-05-30
WO1985005553A1 (en) 1985-12-19
EP0163623B1 (en) 1990-05-09
FI860417A0 (fi) 1986-01-29
FI860417A (fi) 1986-01-29
SE454403B (sv) 1988-05-02
JPS61502334A (ja) 1986-10-16
FI84431C (fi) 1991-12-10
EP0163623A2 (en) 1985-12-04
IE59203B1 (en) 1994-01-26
NO164992C (no) 1990-12-05
NO164992B (no) 1990-08-27
CA1340401C (en) 1999-02-23
ES543635A0 (es) 1988-11-01
SE8402938L (sv) 1985-12-01
JPH0747541B2 (ja) 1995-05-24
AU600886B2 (en) 1990-08-30
NZ212244A (en) 1989-03-29

Similar Documents

Publication Publication Date Title
ES8900019A1 (es) Un procedimiento para fabricar una proteina de la superficiede las celulas
MY130047A (en) Methods and compositions employing certain lysozymes and endoglycosidases
DE3888274D1 (de) Vorrichtung zur intensiven und kontrollierten Herstellung von Mikroorganismen durch Photosynthese.
ATE130031T1 (de) Verwendungen viraler enzyme.
EP0077734A3 (en) Production of monoclonal antibodies against bacterial adhesins
HUT35010A (en) Process for the isolation of substances produced by bacteria
GB2211068B (en) Bacterial treatment to preserve hay quality by addition of microorganisms of the genus bacillus
MY109486A (en) Method employing type ii endoglycosidase
DE2963289D1 (en) Bacterial beta-galactosidase, immobilized forms thereof, process for their preparation and use in the hydrolysis of lactose, and novel bacteria
ZA859525B (en) Micro-organisms of the phanerochaete chrysosporium strain and their use
ES2066468T3 (es) Enzimas con actividad xilanolitica.
DE3884735D1 (de) Material für die fischerei, ausgezeichnet zur verhinderung des anklebens von mikroorganismen,und verfahreen zu dessen herstellung.
NO893643D0 (no) Fremgangsmaate for oekning av enzymaktivitet og syntesekapasitet av organismer.
AU7293387A (en) Process for the treatment of milk for cheesemaking
AU1786300A (en) Gram-positive bacteria deprived of htra proteasic activity and their uses
FR2406393A1 (fr) Produits laitiers a faible teneur en lactose par l'usage de saccharomyces fragilis, et leur procede
DE3884922D1 (de) Verfahren zur Herstellung von thermostabilen alpha-Amylasen durch Kultivierung von überproduzierenden Mikroorganismen.
AT312542B (de) Verfahren zur Herstellung keimarmer Enzympräparate aus mit mikroorganismen verunreinigten enzymhaltigen Präparaten bzw. Rohpräparaten, insbesondere aus Pflanzenextrakten, wie Bromelain, Papain oder Ficin
UA10676A (uk) Штаммбактерій васіllus сіrсulаns бт вкпм в-5622продуцеhт комплексу пектолітичhих фермеhтів і ксілаhази
ATE23189T1 (de) Verfahren zur herstellung von sphaerischen zellaggregaten von mikroorganismen.
AU259629B2 (en) Shaped structures of synthetic material as carrier for enzymes or enzyme-containing. microorganisms in biological processes
AU668761A (en) Shaped structures of synthetic material as carrier for enzymes or enzyme-containing. microorganisms in biological processes
JPS5542536A (en) Preparation of antibiotic substance ns-5
ATE63943T1 (de) Verfahren zur herstellung von mikroorganismen, insbesondere der gruppe frankia, und herstellung eines bakterieninokulums.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20080908